 |
|
Sign in to view your progression
|
This activity is jointly provided by The France Foundation and the International Society on Thrombosis and Haemostasis.
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other healthcare professionals completing this course will be issued a statement of participation.
DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) and International Society on Thrombosis and Haemostasis (ISTH) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF and ISTH resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ISTH seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ISTH are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
|
Name of Individual |
Role in Activity |
Name of Commercial Interest(s) |
Nature of Relationship(s) |
Mechanism(s) implemented to resolve conflict of interest |
|
Amanda Noe |
TFF Staff |
No relevant financial relationships |
NA |
NA |
|
Ana Boban, MD |
Planning Committee Chair, Faculty |
|
|
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Member
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning |
|
Carmen Escuriola, MD |
Planning Committee Member, Faculty |
|
|
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Member
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning |
|
Cary Clark |
ISTH Staff |
No relevant financial relationships |
NA |
NA |
|
Debra Fernandez |
TFF Staff |
No relevant financial relationships |
NA |
NA |
|
Heather Tarbox, MPH |
TFF Staff |
No relevant financial relationships |
NA |
NA |
|
Patrick Harty, PhD |
TFF Staff, TFF Content Reviewer |
No relevant financial relationships |
NA |
NA |
|
Víctor Jiménez Yuste, MD |
Planning Committee Member, Faculty |
|
|
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Member
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning |
Disclosure of Unlabeled Use
TFF and ISTH require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and ISTH recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Sanofi.
MEDIA DISCLOSURE
Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped, or recorded during the meeting by The France Foundation, its educational collaborators, or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos, or recordings that contain your likeness, image, or voice in any educational, informational, commercial, or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.
DISCLAIMER
TFF and ISTH present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. TFF, ISTH, and the commercial supporter(s) assume no liability for the information herein.
CONTACT INFORMATION
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.
Upon completion of the activity, participants should be able to:
- Identify how natural anticoagulants interact with clotting factors and other physiologic pathways to create necessary hemostatic and anti-inflammatory balance
- Compare and contrast the hemostatic targets of emerging rebalancing therapies
- Identify potential clinical impact of rebalancing agents in the treatment of hemophilia
This educational activity is intended for members of the hemophilia care team, including pharmacists, physicians (MD/DO), nurse practitioners (NP), physician associates (PA), as well as other specialists who treat bleeding and clotting disorders.
|
LIVE SESSION
Finding the Balance: Exploring the Role of Natural Anticoagulants
|
|
|
ON-DEMAND
Finding the Balance: Exploring the Role of Natural Anticoagulants
|
|